Stock listing

Sensorion Sas

Selected listing: ALSEN · EURONEXT · EUR · FR

Sensorion Sas (Euronext:ALSEN), Health Technology. Latest release Sep 18, 2026: Sensorion Announces Connection Details for its SENS-601 Program Day…

ALSEN:EURONEXTEURFRUpdated October 3, 2026

Ticker: Euronext:ALSEN
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Sensorion Sas

The company focuses on developing innovative therapies for hearing disorders. Its research and development efforts aim to address unmet medical needs in the field of auditory health.

Latest news from Sensorion Sas

Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026

September 18, 2026

Sensorion Announces Confidential Submission of Draft Registration Statement to the SEC for Potential U.S. Initial Public Offering

September 16, 2026

Sensorion Announces the Completion of Its Reverse Share Split

September 15, 2026

Sensorion Announces Approval of Clinical Trial Application in France for SENS-601, Its Investigational Gene Therapy for the Treatment of GJB2-Related Hearing Loss

September 3, 2026

Sensorion Announces a Reverse Share Split of its Shares

July 29, 2026

All Sensorion Sas news →

Research Sensorion Sas

Sensorion Sas company profile

View the public company page for Sensorion Sas on 6ix.

Sensorion Sas news

Read company news and market updates connected to Sensorion Sas.

Sensorion Sas investor events

Find investor webinars, events, and replay context for Sensorion Sas.